These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 1666545

  • 21. Conformation of tachyplesin I from Tachypleus tridentatus when interacting with lipid matrices.
    Park NG, Lee S, Oishi O, Aoyagi H, Iwanaga S, Yamashita S, Ohno M.
    Biochemistry; 1992 Dec 08; 31(48):12241-7. PubMed ID: 1457421
    [Abstract] [Full Text] [Related]

  • 22. Use of Natural Antimicrobial Peptides and Bacterial Biopolymers for Cultured Pearl Production.
    Simon-Colin C, Gueguen Y, Bachere E, Kouzayha A, Saulnier D, Gayet N, Guezennec J.
    Mar Drugs; 2015 Jun 11; 13(6):3732-44. PubMed ID: 26110895
    [Abstract] [Full Text] [Related]

  • 23. A comparative study of the solution structures of tachyplesin I and a novel anti-HIV synthetic peptide, T22 ([Tyr5,12, Lys7]-polyphemusin II), determined by nuclear magnetic resonance.
    Tamamura H, Kuroda M, Masuda M, Otaka A, Funakoshi S, Nakashima H, Yamamoto N, Waki M, Matsumoto A, Lancelin JM.
    Biochim Biophys Acta; 1993 May 13; 1163(2):209-16. PubMed ID: 8490053
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Interactions of an antimicrobial peptide, tachyplesin I, with lipid membranes.
    Matsuzaki K, Fukui M, Fujii N, Miyajima K.
    Biochim Biophys Acta; 1991 Nov 18; 1070(1):259-64. PubMed ID: 1751532
    [Abstract] [Full Text] [Related]

  • 26. Effects of tachyplesin on proliferation and differentiation of human hepatocellular carcinoma SMMC-7721 cells.
    Ouyang GL, Li QF, Peng XX, Liu QR, Hong SG.
    World J Gastroenterol; 2002 Dec 18; 8(6):1053-8. PubMed ID: 12439924
    [Abstract] [Full Text] [Related]

  • 27. [Tachyplesin-induced differentiation of human hepatocarcinoma cell line SMMC-7721].
    Li QF, Ouyang GL, Liu QR, Hong SG.
    Ai Zheng; 2002 May 18; 21(5):480-3. PubMed ID: 12452036
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Modified horseshoe crab peptides target and kill bacteria inside host cells.
    Amiss AS, von Pein JB, Webb JR, Condon ND, Harvey PJ, Phan MD, Schembri MA, Currie BJ, Sweet MJ, Craik DJ, Kapetanovic R, Henriques ST, Lawrence N.
    Cell Mol Life Sci; 2021 Dec 31; 79(1):38. PubMed ID: 34971427
    [Abstract] [Full Text] [Related]

  • 30. Mechanism of tachyplesin I injury to bacterial membranes and intracellular enzymes, determined by laser confocal scanning microscopy and flow cytometry.
    Hong J, Guan W, Jin G, Zhao H, Jiang X, Dai J.
    Microbiol Res; 2015 Jan 31; 170():69-77. PubMed ID: 25267486
    [Abstract] [Full Text] [Related]

  • 31. Deletion of all cysteines in tachyplesin I abolishes hemolytic activity and retains antimicrobial activity and lipopolysaccharide selective binding.
    Ramamoorthy A, Thennarasu S, Tan A, Gottipati K, Sreekumar S, Heyl DL, An FY, Shelburne CE.
    Biochemistry; 2006 May 23; 45(20):6529-40. PubMed ID: 16700563
    [Abstract] [Full Text] [Related]

  • 32. Anti-human immunodeficiency virus activity of a novel synthetic peptide, T22 ([Tyr-5,12, Lys-7]polyphemusin II): a possible inhibitor of virus-cell fusion.
    Nakashima H, Masuda M, Murakami T, Koyanagi Y, Matsumoto A, Fujii N, Yamamoto N.
    Antimicrob Agents Chemother; 1992 Jun 23; 36(6):1249-55. PubMed ID: 1384424
    [Abstract] [Full Text] [Related]

  • 33. Functional conversion of hemocyanin to phenoloxidase by horseshoe crab antimicrobial peptides.
    Nagai T, Osaki T, Kawabata S.
    J Biol Chem; 2001 Jul 20; 276(29):27166-70. PubMed ID: 11375396
    [Abstract] [Full Text] [Related]

  • 34. Solution and micelle-bound structures of tachyplesin I and its active aromatic linear derivatives.
    Laederach A, Andreotti AH, Fulton DB.
    Biochemistry; 2002 Oct 15; 41(41):12359-68. PubMed ID: 12369825
    [Abstract] [Full Text] [Related]

  • 35. Bactericidal action of tachyplesin I against oral streptococci.
    Masuda K, Ohta M, Ito M, Ohsuka S, Kaneda T, Kato N.
    Oral Microbiol Immunol; 1994 Apr 15; 9(2):77-80. PubMed ID: 8008433
    [Abstract] [Full Text] [Related]

  • 36. A novel big defensin identified in horseshoe crab hemocytes: isolation, amino acid sequence, and antibacterial activity.
    Saito T, Kawabata S, Shigenaga T, Takayenoki Y, Cho J, Nakajima H, Hirata M, Iwanaga S.
    J Biochem; 1995 May 15; 117(5):1131-7. PubMed ID: 8586631
    [Abstract] [Full Text] [Related]

  • 37. Cyclic Analogues of Horseshoe Crab Peptide Tachyplesin I with Anticancer and Cell Penetrating Properties.
    Vernen F, Craik DJ, Lawrence N, Troeira Henriques S.
    ACS Chem Biol; 2019 Dec 20; 14(12):2895-2908. PubMed ID: 31714739
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. RGD-Tachyplesin inhibits tumor growth.
    Chen Y, Xu X, Hong S, Chen J, Liu N, Underhill CB, Creswell K, Zhang L.
    Cancer Res; 2001 Mar 15; 61(6):2434-8. PubMed ID: 11289111
    [Abstract] [Full Text] [Related]

  • 40. Horseshoe crab hemocyte-derived antimicrobial polypeptides, tachystatins, with sequence similarity to spider neurotoxins.
    Osaki T, Omotezako M, Nagayama R, Hirata M, Iwanaga S, Kasahara J, Hattori J, Ito I, Sugiyama H, Kawabata S.
    J Biol Chem; 1999 Sep 10; 274(37):26172-8. PubMed ID: 10473569
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.